• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

GE Unveils Edison Healthcare Artificial Intelligence Platform

Share:

December 4, 2018

GE Healthcare has unveiled its Edison healthcare artificial intelligence platform designed to connect data on millions of medical imaging devices.

The company said that clinical partners will be able to use Edison to develop algorithms and technology partners will be able to bring data processing advancements to Edison applications and smart devices.

A full 90 percent of healthcare data comes from imaging technology, yet 97 percent goes unanalyzed or unused, GE Healthcare said.

Edison is designed to harness that data to improve scan consistency, detect and prioritize cases, and extend the lifecycle of devices.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Edison powers pioneering but practical technologies that improve the workflows and devices of today and target the greatest pain points in the system,” said GE Healthcare Senior Vice President of Edison Portfolio Strategy Keith Bigelow.

“Thanks to advances in computing power and data science, we have entered a new era of medicine,” said Michael Blum, associate vice chancellor for informatics at the University of California, San Diego. “We now have a tremendous opportunity to improve the quality and efficiency of care, and prevention and prediction for an individual are finally going to be possible.”

New apps, smart devices built on Edison platform

GE Healthcare also announced several healthcare apps and smart devices built on the Edison platform:

  • AIRx — This AI-based automated workflow tool is used for MRI brain scanning to improve consistency and productivity. AIRx uses deep learning and anatomy recognition to learn from a database of more than 36,000 brain images to reduce the number of manual steps for radiologists during brain scans. It is designed to produce images that have less variability between technologists and between scans to help reduce the need for repeat scanning due to incorrect slice placement.
  • CT Smart Subscription — This subscription service provides continuous access to the latest CT software. Apps can be selected based on a hospital or health system’s needs, with options ranging from intracranial hemorrhage and stroke detection to routine dose reduction and optimization to cardiac function assessment.
  • Automated Lesion Segmentation on LOGIQ E10 — This helps eliminate the need for the user to manually measure lesions identified by ultrasound by segmenting a breast, thyroid, or liver lesion and automatically providing a trace of the lesion and corresponding area.
  • Critical Care Suite on Optima XR240amx — This device is designed to identify cases of pneumothorax to enable prioritization of image review. It uses a suite of AI algorithms designed to identify pneumothorax in chest X-rays with high accuracy. The algorithms are hosted on the mobile X-ray system designed to share the output through an onscreen notification.

“There’s a lot of hidden meaning in the deep data, but it takes a significant sophistication to extract the value,” said Rachael Callcut, a partner in the development of Critical Care Suite as well as an associate professor of surgery at UC San Francisco, a surgeon at UCSF Health, and director of data science for the Center for Digital Health Innovation. “AI gives us an opportunity to see patterns that we don’t see and change the way we care for patients, which can ultimately improve outcomes,” Callcut added.

Callcut partnered with radiology colleagues and GE Healthcare to create an initial algorithm that can immediately detect pneumothorax, a condition which can be deadly if not diagnosed quickly and accurately. Pneumothorax affects nearly 74,000 US patients each year.

“The concept behind this was to develop an algorithm using artificial intelligence that could actually learn how to find pneumothorax on a chest X-Ray,” Callcut said. “And by alerting the clinicians immediately, it would allow us to actually speed up the timely diagnosis of a potentially life-threatening condition.”

GE Healthcare said it intends to open the Edison platform and over 100 services to more developers and partners, which could accelerate the development and adoption of AI technology in healthcare.

Date: December 5, 2018

Source: HIT Infrastructure

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • CoorsTek Medical Becomes Lincotek MedicalCoorsTek Medical Becomes Lincotek Medical
  • Autobahn Therapeutics Acquires Clinical-Stage FAAH Inhibitor from Astellas, Strengthening Its Brain Targeting Chemistry PlatformAutobahn Therapeutics Acquires Clinical-Stage FAAH Inhibitor from Astellas, Strengthening Its Brain Targeting Chemistry Platform
  • COVID-19 Death Rates: Which States are Really Flattening the Curve?COVID-19 Death Rates: Which States are Really Flattening the Curve?
  • Health & Safety Institute Acquires Martech Media, Inc.Health & Safety Institute Acquires Martech Media, Inc.
  • Oatmeal Health Brings AI-Powered Lung Cancer Screening to The Clinic in OklahomaOatmeal Health Brings AI-Powered Lung Cancer Screening to The Clinic in Oklahoma
  • Q&A: Dexcom CEO Talks Rapid Pace of CGM Innovation, What’s Coming in 2020 and BeyondQ&A: Dexcom CEO Talks Rapid Pace of CGM Innovation, What’s Coming in 2020 and Beyond
  • Walmart Health Continues 2024 Expansion into OklahomaWalmart Health Continues 2024 Expansion into Oklahoma
  • ALK Acquires OTIPRIO® (Ciprofloxacin Otic Suspension), Broadening Treatment Solutions for Healthcare Providers and PatientsALK Acquires OTIPRIO® (Ciprofloxacin Otic Suspension), Broadening Treatment Solutions for Healthcare Providers and Patients

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications